AI-Powered Biomarker Discovery: From Screening to Translational Insights
Biomarker discovery is essential to advancing precision medicine, yet researchers face common challenges: complex assays that generate massive datasets, imaging workflows that are difficult to scale and connecting results into actionable insights remains a struggle. These barriers slow discovery, limit reproducibility and make it harder to translate findings into clinical impact.
In this webinar, discover how Leica Microsystems and Molecular Devices, life sciences companies of Danaher, address these challenges through integrated, AI-powered solutions. Learn how advanced imaging and analytics platforms accelerate phenotypic screening, reveal spatial and morphological context and help you move from data to discovery with greater speed, confidence and translational relevance.
Key takeaways:
- Gain spatial insights and cellular context using Aivia AI Image Analysis Software from Leica Microsystems
- Reduce the time and complexity of phenotypic screening with IN Carta Image Analysis Software from Molecular Devices
Speakers
Choi, Won Yung, Ph.D, Product Manager and Scientific Innovation Manager AI, Leica Microsystems
Won Yung Choi, Ph.D. is Product Manager and Scientific Innovation Manager AI, at Leica Microsystems, intended to enable more closely connected support in evaluating AI technologies and fostering cooperation within Danaher’s AI-related initiatives to drive our product innovation. Won Yung received her Ph.D. in dopaminergic circuitry changes during learning from Columbia University, New York, USA. In the last two decades, Won Yung has been involved in advanced microscopy and image analysis starting as a postdoc researcher at Columbia, then as the National Sales and Support Manager of Imaris Americas (Oxford Instruments), before joining Leica as Product Owner - Product Manager for Aivia AI Image Analysis Software to drive R&D to create smarter AI-driven image analysis solutions to get from eye to insights faster.
Oksana Sirenko, PhD, Sr. Manager, Assay Development, Molecular Devices
Dr. Oksana Sirenko is a Sr. Scientist and Sr. Manager of Assay Development at Molecular Devices, with expertise in cell biology, high content imaging and assay automation. Having extensive experience in drug development and drug discovery Dr. Sirenko is leading a group of scientists developing assays with complex cell-based models as well as assay automation of 2D or 3D cell models, including stem cells, tumoroids, organoids and organ-on chip. Dr. Sirenko holds a PhD in Biochemistry/Biophysics, has over 15 years of industry experience at pharma and Biotech, and has authored more than 35 scientific papers.
gatedform
gatedform
546005641
lms-moldev-digitalai-wbn
add
Other
promotion
https://lifesciences.danaher.com/
https://help.salesforce.com/s/articleView?id=sf.mc_es_demanager.htm